查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530943

核酸适体市场 - 2024-2034 年全球产业分析、份额、份额、成长、趋势和预测

Nucleic Acid Aptamers Market - Global Industry Analysis, Share, Share, Growth, Trends, and Forecast 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 174 Pages | 商品交期: 2-10个工作天内

价格

核酸适体市场 - 报告范围

TMR 关于全球核酸适体市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。期间的市场，考虑2024年为基准年，2034年为预测年。报告也提供了2024年至2034年全球核酸适体市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解核酸适体市场。

市场概况
2023年市场价值 2.199 亿美元
2034 年市场价值 12亿美元
复合年增长率 17.2%

该报告深入探讨了全球核酸适体市场的竞争格局。全球核酸适体市场的主要参与者已被确定，并且每位参与者的各种属性都已被描述。公司概况、财务状况、近期发展和 SWOT 是本报告中介绍的全球核酸适体市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034 年全球市场分析与预测

第 5 章：关键见解

  • 技术进步
  • PORTERs 五力分析
  • 价值链分析

第 6 章：全球市场分析与预测：按类型

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按类型分類的市场价值预测
    • DNA适体
    • RNA适体
    • XNA适体
  • 按类型分類的市场吸引力

第 7 章：全球市场分析与预测：按应用分类

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按应用分類的市场价值预测
    • 药物输送
    • 抗病毒治疗
    • 病原体识别
    • 疾病识别
    • 干细胞标记物
    • 其他的
  • 按应用分類的市场吸引力

第 8 章：全球市场分析与预测：依指标分类

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年市场价值预测（依指标）
    • 病毒感染
    • 癌症
    • 眼科
    • 其他的
  • 按指标分類的市场吸引力

第 9 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年最终用户市场价值预测
    • 生物製药公司
    • 诊断中心
    • 合约研究组织
    • 其他的
  • 最终用户的市场吸引力

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按国家/地区分類的市场吸引力

第 11 章：北美市场分析与预测

  • 我们
  • 加拿大

第 12 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区

第 13 章：亚太市场分析与预测

  • 中国
  • 印度
  • 日本
  • 澳洲和纽西兰
  • 亚太地区其他地区

第 14 章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 15 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司简介
    • Aptagen Labs
    • Aptamer Group
    • Base Pair Biotechnologies
    • NeoVentures Biotechnology Inc.
    • Aptamer Sciences, Inc.
    • SomaLogic Operating Co., Inc.
    • AptaTargets SL.
    • Aptus Biotech SL
    • Other Prominent Players
Product Code: TMRGL1330

Nucleic Acid Aptamers Market - Scope of Report

TMR's report on the global nucleic acid aptamers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global nucleic acid aptamers market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nucleic acid aptamers market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the nucleic acid aptamers market.

Market Snapshot
Market Value in 2023US$ 219.9 Mn
Market Value in 2034US$ 1.2 Bn
CAGR17.2%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nucleic acid aptamers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nucleic acid aptamers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nucleic acid aptamers market.

The report delves into the competitive landscape of the global nucleic acid aptamers market. Key players operating in the global nucleic acid aptamers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nucleic acid aptamers market profiled in this report.

Key Questions Answered in Global nucleic acid aptamers Market Report:

  • What is the sales/revenue generated by nucleic acid aptamers across all regions during the forecast period?
  • What are the opportunities in the global nucleic acid aptamers market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Nucleic Acid Aptamers Market - Research Objectives and Research Approach

The comprehensive report on the global nucleic acid aptamers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nucleic acid aptamers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nucleic acid aptamers market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nucleic Acid Aptamers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Type Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Nucleic Acid Aptamers Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. PORTERs Five Forces Analysis
  • 5.3. Value Chain Analysis

6. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type, 2020-2034
    • 6.3.1. DNA Aptamer
    • 6.3.2. RNA Aptamer
    • 6.3.3. XNA Aptamer
  • 6.4. Market Attractiveness By Type

7. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020-2034
    • 7.3.1. Drug Delivery
    • 7.3.2. Anti-viral Therapy
    • 7.3.3. Pathogen Recognition
    • 7.3.4. Disease Recognition
    • 7.3.5. Stem Cell Markers
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Application

8. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Indication

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Indication, 2020-2034
    • 8.3.1. Viral infection
    • 8.3.2. Cancer
    • 8.3.3. Ophthalmology
    • 8.3.4. Others
  • 8.4. Market Attractiveness By Indication

9. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2020-2034
    • 9.3.1. Biopharmaceutical Companies
    • 9.3.2. Diagnostic Centers
    • 9.3.3. CROs
    • 9.3.4. Others
  • 9.4. Market Attractiveness By End-user

10. Global Nucleic Acid Aptamers Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Nucleic Acid Aptamers Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Type, 2020-2034
    • 11.2.1. DNA Aptamer
    • 11.2.2. RNA Aptamer
    • 11.2.3. XNA Aptamer
  • 11.3. Market Value Forecast By Application, 2020-2034
    • 11.3.1. Drug-Delivery
    • 11.3.2. Anti-viral Therapy
    • 11.3.3. Pathogen Recognition
    • 11.3.4. Disease Recognition
    • 11.3.5. Stem Cell Markers
    • 11.3.6. Others
  • 11.4. Market Value Forecast By Indication, 2020-2034
    • 11.4.1. Viral infection
    • 11.4.2. Cancer
    • 11.4.3. Ophthalmology
    • 11.4.4. Others
  • 11.5. Market Value Forecast By End-user, 2020-2034
    • 11.5.1. Biopharmaceutical Companies
    • 11.5.2. Diagnostic Centers
    • 11.5.3. CROs
    • 11.5.4. Others
  • 11.6. Market Value Forecast By Country, 2020-2034
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Type
    • 11.7.2. By Application
    • 11.7.3. By Indication
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Nucleic Acid Aptamers Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Type, 2020-2034
    • 12.2.1. DNA Aptamer
    • 12.2.2. RNA Aptamer
    • 12.2.3. XNA Aptamer
  • 12.3. Market Value Forecast By Application, 2020-2034
    • 12.3.1. Drug-Delivery
    • 12.3.2. Anti-viral Therapy
    • 12.3.3. Pathogen Recognition
    • 12.3.4. Disease Recognition
    • 12.3.5. Stem Cell Markers
    • 12.3.6. Others
  • 12.4. Market Value Forecast By Indication, 2020-2034
    • 12.4.1. Viral infection
    • 12.4.2. Cancer
    • 12.4.3. Ophthalmology
    • 12.4.4. Others
  • 12.5. Market Value Forecast By End-user, 2020-2034
    • 12.5.1. Biopharmaceutical Companies
    • 12.5.2. Diagnostic Centers
    • 12.5.3. CROs
    • 12.5.4. Others
  • 12.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Type
    • 12.7.2. By Application
    • 12.7.3. By Indication
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Nucleic Acid Aptamers Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type, 2020-2034
    • 13.2.1. DNA Aptamer
    • 13.2.2. RNA Aptamer
    • 13.2.3. XNA Aptamer
  • 13.3. Market Value Forecast By Application, 2020-2034
    • 13.3.1. Drug-Delivery
    • 13.3.2. Anti-viral Therapy
    • 13.3.3. Pathogen Recognition
    • 13.3.4. Disease Recognition
    • 13.3.5. Stem Cell Markers
    • 13.3.6. Others
  • 13.4. Market Value Forecast By Indication, 2020-2034
    • 13.4.1. Viral infection
    • 13.4.2. Cancer
    • 13.4.3. Ophthalmology
    • 13.4.4. Others
  • 13.5. Market Value Forecast By End-user, 2020-2034
    • 13.5.1. Biopharmaceutical Companies
    • 13.5.2. Diagnostic Centers
    • 13.5.3. CROs
    • 13.5.4. Others
  • 13.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 13.6.1. China
    • 13.6.2. India
    • 13.6.3. Japan
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Type
    • 13.7.2. By Application
    • 13.7.3. By Indication
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Nucleic Acid Aptamers Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type, 2020-2034
    • 14.2.1. DNA Aptamer
    • 14.2.2. RNA Aptamer
    • 14.2.3. XNA Aptamer
  • 14.3. Market Value Forecast By Application, 2020-2034
    • 14.3.1. Drug-Delivery
    • 14.3.2. Anti-viral Therapy
    • 14.3.3. Pathogen Recognition
    • 14.3.4. Disease Recognition
    • 14.3.5. Stem Cell Markers
    • 14.3.6. Others
  • 14.4. Market Value Forecast By Indication, 2020-2034
    • 14.4.1. Viral infection
    • 14.4.2. Cancer
    • 14.4.3. Ophthalmology
    • 14.4.4. Others
  • 14.5. Market Value Forecast By End-user, 2020-2034
    • 14.5.1. Biopharmaceutical Companies
    • 14.5.2. Diagnostic Centers
    • 14.5.3. CROs
    • 14.5.4. Others
  • 14.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Type
    • 14.7.2. By Application
    • 14.7.3. By Indication
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Nucleic Acid Aptamers Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Type, 2020-2034
    • 15.2.1. DNA Aptamer
    • 15.2.2. RNA Aptamer
    • 15.2.3. XNA Aptamer
  • 15.3. Market Value Forecast By Application, 2020-2034
    • 15.3.1. Drug-Delivery
    • 15.3.2. Anti-viral Therapy
    • 15.3.3. Pathogen Recognition
    • 15.3.4. Disease Recognition
    • 15.3.5. Stem Cell Markers
    • 15.3.6. Others
  • 15.4. Market Value Forecast By Indication, 2020-2034
    • 15.4.1. Viral infection
    • 15.4.2. Cancer
    • 15.4.3. Ophthalmology
    • 15.4.4. Others
  • 15.5. Market Value Forecast By End-user, 2020-2034
    • 15.5.1. Biopharmaceutical Companies
    • 15.5.2. Diagnostic Centers
    • 15.5.3. CROs
    • 15.5.4. Others
  • 15.6. Market Value Forecast By Country/Sub-region, 2020-2034
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Type
    • 15.7.2. By Application
    • 15.7.3. By Indication
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Company Profiles
    • 16.2.1. Aptagen Labs
      • 16.2.1.1. Company Overview
      • 16.2.1.2. Financial Overview
      • 16.2.1.3. Product Portfolio
      • 16.2.1.4. Business Strategies
      • 16.2.1.5. Recent Developments
    • 16.2.2. Aptamer Group
      • 16.2.2.1. Company Overview
      • 16.2.2.2. Financial Overview
      • 16.2.2.3. Product Portfolio
      • 16.2.2.4. Business Strategies
      • 16.2.2.5. Recent Developments
    • 16.2.3. Base Pair Biotechnologies
      • 16.2.3.1. Company Overview
      • 16.2.3.2. Financial Overview
      • 16.2.3.3. Product Portfolio
      • 16.2.3.4. Business Strategies
      • 16.2.3.5. Recent Developments
    • 16.2.4. NeoVentures Biotechnology Inc.
      • 16.2.4.1. Company Overview
      • 16.2.4.2. Financial Overview
      • 16.2.4.3. Product Portfolio
      • 16.2.4.4. Business Strategies
      • 16.2.4.5. Recent Developments
    • 16.2.5. Aptamer Sciences, Inc.
      • 16.2.5.1. Company Overview
      • 16.2.5.2. Financial Overview
      • 16.2.5.3. Product Portfolio
      • 16.2.5.4. Business Strategies
      • 16.2.5.5. Recent Developments
    • 16.2.6. SomaLogic Operating Co., Inc.
      • 16.2.6.1. Company Overview
      • 16.2.6.2. Financial Overview
      • 16.2.6.3. Product Portfolio
      • 16.2.6.4. Business Strategies
      • 16.2.6.5. Recent Developments
    • 16.2.7. AptaTargets SL.
      • 16.2.7.1. Company Overview
      • 16.2.7.2. Financial Overview
      • 16.2.7.3. Product Portfolio
      • 16.2.7.4. Business Strategies
      • 16.2.7.5. Recent Developments
    • 16.2.8. Aptus Biotech S.L.
      • 16.2.8.1. Company Overview
      • 16.2.8.2. Financial Overview
      • 16.2.8.3. Product Portfolio
      • 16.2.8.4. Business Strategies
      • 16.2.8.5. Recent Developments
    • 16.2.9. Other Prominent Players
      • 16.2.9.1. Company Overview
      • 16.2.9.2. Financial Overview
      • 16.2.9.3. Product Portfolio
      • 16.2.9.4. Business Strategies
      • 16.2.9.5. Recent Developments

List of Tables

  • Table 01: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 02: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 03: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 04: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
  • Table 05: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 06: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 07: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 08: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 09: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 10: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
  • Table 11: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 13: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 14: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 15: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
  • Table 16: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 18: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 19: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 20: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
  • Table 21: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 23: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 24: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 25: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users, 2020-2034
  • Table 26: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Type, 2020-2034
  • Table 28: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 29: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 30: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, by End-users,

List of Figures

  • Figure 01: Nucleic Acid Aptamers Market Size, by Type, 2023
  • Figure 02: Nucleic Acid Aptamers Market share (%), by Type, 2023
  • Figure 03: Nucleic Acid Aptamers Market Size, by Application, 2023
  • Figure 04: Nucleic Acid Aptamers Market share (%), by Application, 2023
  • Figure 05: Nucleic Acid Aptamers Market Size, by Indication, 2023
  • Figure 06: Nucleic Acid Aptamers Market share (%), by Application, 2023
  • Figure 07: Nucleic Acid Aptamers Market Size, by End-users, 2023
  • Figure 08: Nucleic Acid Aptamers Market share (%), by End-users, 2023
  • Figure 09: Global Nucleic Acid Aptamers Market, By Region (2023 and 2034)
  • Figure 10: Global Nucleic Acid Aptamers Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 11: Global Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 12: Global Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023
  • Figure 13: Global Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2034
  • Figure 14: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
  • Figure 15: Global Nucleic Acid Aptamers Market Value (US$ Mn), by DNA Aptamer, 2020-2034
  • Figure 16: Global Nucleic Acid Aptamers Market Value Share Analysis, by DNA Aptamer, 2023 and 2034
  • Figure 17: Global Nucleic Acid Aptamers Market Value (US$ Mn), by RNA Aptamer, 2020-2034
  • Figure 18: Global Nucleic Acid Aptamers Market Value Share Analysis, RNA Aptamer, 2023 and 2034
  • Figure 19: Global Nucleic Acid Aptamers Market Value (US$ Mn), by XNA Aptamer, 2020-2034
  • Figure 20: Global Nucleic Acid Aptamers Market Value Share Analysis, by XNA Aptamer, 2023 and 2034
  • Figure 21: Global Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 22: Global Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023
  • Figure 23: Global Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2034
  • Figure 24: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 25: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Drug-Delivery, 2020-2034
  • Figure 26: Global Nucleic Acid Aptamers Market Value Share Analysis, by Drug-Delivery, 2023 and 2034
  • Figure 27: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Anti-Viral Therapy, 2020-2034
  • Figure 28: Global Nucleic Acid Aptamers Market Value Share Analysis, Anti-Viral Therapy, 2023 and 2034
  • Figure 29: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Pathogen Recognition, 2020-2034
  • Figure 30: Global Nucleic Acid Aptamers Market Value Share Analysis, by Pathogen Recognition, 2023 and 2034
  • Figure 31: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Disease Recognition, 2020-2034
  • Figure 32: Global Nucleic Acid Aptamers Market Value Share Analysis, Disease Recognition, 2023 and 2034
  • Figure 33: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Stem Cell Markers, 2020-2034
  • Figure 34: Global Nucleic Acid Aptamers Market Value Share Analysis, by Stem Cell Markers, 2023 and 2034
  • Figure 35: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Others, 2020-2034
  • Figure 36: Global Nucleic Acid Aptamers Market Value Share Analysis, Others, 2023 and 2034
  • Figure 37: Global Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 38: Global Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023
  • Figure 39: Global Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2034
  • Figure 40: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 41: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Viral Infection, 2020-2034
  • Figure 42: Global Nucleic Acid Aptamers Market Value Share Analysis, by Viral Infection, 2023 and 2034
  • Figure 43: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Cancer, 2020-2034
  • Figure 44: Global Nucleic Acid Aptamers Market Value Share Analysis, Cancer, 2023 and 2034
  • Figure 45: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Ophthalmology, 2020-2034
  • Figure 46: Global Nucleic Acid Aptamers Market Value Share Analysis, by Ophthalmology, 2023 and 2034
  • Figure 47: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Others, 2020-2034
  • Figure 48: Global Nucleic Acid Aptamers Market Value Share Analysis, Others, 2023 and 2034
  • Figure 49: Global Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
  • Figure 50: Global Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023
  • Figure 51: Global Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2034
  • Figure 52: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
  • Figure 53: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Biopharmaceutical Companies, 2020-2034
  • Figure 54: Global Nucleic Acid Aptamers Market Value Share Analysis, by Biopharmaceutical Companies, 2023 and 2034
  • Figure 55: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Diagnostic Centers, 2020-2034
  • Figure 56: Global Nucleic Acid Aptamers Market Value Share Analysis, Diagnostic Centers, 2023 and 2034
  • Figure 57: Global Nucleic Acid Aptamers Market Value (US$ Mn), by CROs, 2020-2034
  • Figure 58: Global Nucleic Acid Aptamers Market Value Share Analysis, by CROs, 2023 and 2034
  • Figure 59: Global Nucleic Acid Aptamers Market Value (US$ Mn), by Others, 2020-2034
  • Figure 60: Global Nucleic Acid Aptamers Market Value Share Analysis, Hospitals, 2023 and 2034
  • Figure 61: Global Nucleic Acid Aptamers Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 62: Global Nucleic Acid Aptamers Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 63: North America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 64: North America Nucleic Acid Aptamers Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 65: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by Country, 2023-2034
  • Figure 66: North America Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 67: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
  • Figure 68: North America Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 69: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 70: North America Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 71: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 72: North America Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
  • Figure 73: North America Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
  • Figure 74: Europe Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 75: Europe Nucleic Acid Aptamers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 76: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 77: Europe Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 78: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
  • Figure 79: Europe Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 80: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 81: Europe Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 82: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 83: Europe Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
  • Figure 84: Europe Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
  • Figure 85: Asia Pacific Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 86: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 87: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 88: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 89: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
  • Figure 90: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 91: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 92: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 93: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 94: Asia Pacific Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
  • Figure 95: Asia Pacific Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
  • Figure 96: Latin America Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 97: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 98: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 99: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 100: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
  • Figure 101: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 102: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 103: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 104: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 105: Latin America Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
  • Figure 106: Latin America Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034
  • Figure 107: Middle East & Africa Nucleic Acid Aptamers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 108: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 109: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by Country/Sub-region, 2023-2034
  • Figure 110: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by Type, 2023 and 2034
  • Figure 111: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by Type, 2023-2034
  • Figure 112: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by Application, 2023 and 2034
  • Figure 113: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by Application, 2023-2034
  • Figure 114: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by Indication, 2023 and 2034
  • Figure 115: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by Indication, 2023-2034
  • Figure 116: Middle East & Africa Nucleic Acid Aptamers Market Value Share Analysis, by End-users, 2023 and 2034
  • Figure 117: Middle East & Africa Nucleic Acid Aptamers Market Attractiveness Analysis, by End-users, 2023-2034